申请人:Parker Michael H.
                            
                            
                                公开号:US20110105562A1
                            
                            
                                公开(公告)日:2011-05-05
                            
                            The present invention is directed to novel alkynyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by DPP-1.
                            本发明涉及新颖的炔基衍
生物,含有它们的药物组合物以及它们在治疗受
DPP-1调节的疾病和症状中的应用。